Analyst Ratings for Intercept Pharmaceuticals (ICPT)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 3.9 / 10
Percentile Rank: 38%
Rating Score: 3.9 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/27/2023 | H.C. Wainwright | Ed Arce | Downgrade | Neutral (Buy) |
19.00 (N/A) |
18.71 (19.00) |
1.55% | Details |
| 9/27/2023 | Canaccord | Edward Nash | Downgrade | Hold (Buy) |
19.00 (N/A) |
10.44 (19.00) |
81.99% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


